Dasari A, Shen C, Halperin D, Zhao B, Zhou S, Xu Y, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017;3(10):1335–42. https://doi.org/10.1001/jamaoncol.2017.0589.

Article  PubMed  PubMed Central  Google Scholar 

Ito T, Igarashi H, Nakamura K, Sasano H, Okusaka T, Takano K, et al. Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis. J Gastroenterol. 2015;50:58–64. https://doi.org/10.1007/s00535-014-0934-2.

Article  PubMed  Google Scholar 

Miyake E, Serikawa M, Ishii Y, Tsuboi T, Kurihara K, Tatsukawa Y, et al. The relationship between the degree of histopathological differentiation and imaging findings in pancreatic neuroendocrine neoplasms. SUIZO. 2019;34(2):63–70.

Article  Google Scholar 

Ito T, Masui T, Komoto I, et al. Japanese Neuroendocrine Tumor Society. 2. Clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms (NEN) 2019. Tokyo: Kanehara syuppan; 2019. 

National Comprehensive Cancer Network (NCCN). Clinical practice guidelines in oncology for neuroendocrine and adrenal tumors (Version 1.2022). https://www.nccn.org/professionals/physician_gls/pdf/neuroendocrine.pdf. Accessed 24 Oct 2022.

Falconi M, Eriksson B, Kaltsas G, Bartsch D, Capdevila J, Caplin M, et al. ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors. Neuroendocrinology. 2016;103:153–71. https://doi.org/10.1159/000443171.

Article  CAS  PubMed  Google Scholar 

Muscogiuri G, Altieri B, Albertelli M, Dotto A, Modica R, Barrea L, et al. Epidemiology of pancreatic neuroendocrine neoplasms: a gender perspective. Endocrine. 2020;69:441–50. https://doi.org/10.1007/s12020-020-02331-3.

Article  CAS  PubMed  Google Scholar 

Feola T, Puliani G, Sesti F, Modica R, Centello R, Minotta R, et al. Risk factors for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a three-centric case–control study. J Endocrinol Investig. 2022;45:849–57. https://doi.org/10.1007/s40618-021-01715-0.

Article  CAS  Google Scholar 

Barrea L, Muscogiuri G, Modica R, Altieri B, Pugliese G, Minotta R, et al. Cardio-metabolic indices and metabolic syndrome as predictors of clinical severity of gastroenteropancreatic neuroendocrine tumors. Front Endocrinol (Lausanne). 2021;18(12):649496. https://doi.org/10.3389/fendo.2021.649496.

Article  Google Scholar 

Hashim YM, Trinkaus KM, Linehan DC, Strasberg S, Fields R, Cao D, et al. Regional lymphadenectomy is indicated in the surgical treatment of pancreatic neuroendocrine tumors (PNETs). Ann Surg. 2014;259(2):197–203. https://doi.org/10.1097/SLA.0000000000000348.

Article  PubMed  Google Scholar 

Conrad C, Kutlu O, Dasari A, Chan J, Vauthey J, Adams D, et al. Prognostic value of lymph node status and extent of lymphadenectomy in pancreatic neuroendocrine tumors confined to and extending beyond the pancreas. J Gastrointest Surg. 2016;20:1966–74. https://doi.org/10.1007/s11605-016-3243-7.

Article  PubMed  Google Scholar 

Gratian L, Pura J, Dinan M, Roman S, Reed S, Sosa JA. Impact of extent of surgery on survival in patients with small nonfunctional pancreatic neuroendocrine tumors in the United States. Ann Surg Oncol. 2014;21:3515–21. https://doi.org/10.1245/s10434-014-3769-4.

Article  PubMed  PubMed Central  Google Scholar 

Sallinen V, Large T, Tieftrunk E, Galeev S, Kovalenko Z, Haugvik S, et al. Prognosis of sporadic resected small (≦2 cm) nonfunctional pancreatic neuroendocrine tumors – a multi-institutional study. HPB. 2018;20:251–9. https://doi.org/10.1016/j.hpb.2017.08.034.

Article  PubMed  Google Scholar 

Bettini R, Partelli S, Boninsegna L, Capelli P, Crippa S, Pederzoli P, et al. Tumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumor. Surgery. 2011;150:75–82. https://doi.org/10.1016/j.surg.2011.02.022.

Article  PubMed  Google Scholar 

Tsutsumi K, Ohtsuka T, Fujino M, Nakashima H, Aishima S, Ueda J, et al. Analysis of risk factors for recurrence after curative resection of well-differentiated pancreatic neuroendocrine tumors based on the new grading classification. J Hepatobiliary Pancreat Sci. 2014;21(6):418–25. https://doi.org/10.1002/jhbp.47.

Article  PubMed  Google Scholar 

Falconi M, Zerbi A, Crippa S, Balzano G, Boninsegna L, Capitanio V, et al. Parenchyma-preserving resections for small nonfunctioning pancreatic endocrine tumors. Ann Surg Oncol. 2010;17:1621–7. https://doi.org/10.1245/s10434-010-0949-8.

Article  PubMed  Google Scholar 

Fendrich V, Waldmann J, Bartsch D, Langer P. Surgical management of pancreatic endocrine tumors. Nat Rev Clin Oncol. 2009;6:419–28. https://doi.org/10.1038/nrclinonc.2009.82.

Article  PubMed  Google Scholar 

Partelli S, Cirocchi R, Crippa S, Cardinali L, Fendrich V, Bartsch D, et al. Systematic review of active surveillance versus surgical management of asymptomatic small non-functioning pancreatic neuroendocrine neoplasms. BJS. 2017;104:34–41. https://doi.org/10.1002/bjs.10312.

Article  CAS  Google Scholar 

Jung JG, Lee KT, Woo YS, Lee JK, Lee KH, Jang KT, et al. Behavior of small, asymptomatic, nonfunctioning pancreatic neuroendocrine tumors (NF-PNETs). Medicine. 2015;94(26):1–7. https://doi.org/10.1097/MD.0000000000000983.

Article  Google Scholar 

Rosenberg AM, Friedmann P, Del Rivero J, Libutti SK, Laird AM. Resection versus expectant management of small incidentally discovered nonfunctional pancreatic neuroendocrine tumors. Surgery. 2015;159(1):302–10. https://doi.org/10.1016/j.surg.2015.10.013.

Article  PubMed  Google Scholar 

Bartsch DK, Waldmann J, Fendrich V, Boninsegna L, Lopez C, Partelli S, et al. Impact of lymphadenectomy on survival after surgery for sporadic gastrinoma. BJS. 2012;99(9):1234–40. https://doi.org/10.1002/bjs.8843.

Article  CAS  Google Scholar 

Oberg K. Pancreatic endocrine tumors. Semin Oncol. 2010;37(6):594–618. https://doi.org/10.1053/j.seminoncol.2010.10.014.

Article  CAS  PubMed  Google Scholar 

Norton JA, Fraker DL, Alexander HR, Jensen RT. Value of surgery in patients with negative imaging and sporadic Zollinger-Ellison syndrome. Ann Surg. 2012;256(3):509–17. https://doi.org/10.1097/SLA.0b013e318265f08d.

Article  PubMed  Google Scholar 

Wermers RA, Fatourechi V, Wynne AG, Kvols LK, Lloyd RV. The glucagonoma syndrome. Clinical and pathologic features in 21 patients. Medicine (Baltimore). 1996;75(2):53–63. https://doi.org/10.1097/00005792-199603000-00002.

Article  CAS  Google Scholar 

Hayashi R, Minami I, Sasahara Y, Izumiyama H, Yoshimoto T, Kishino M, et al. Diagnostic accuracy of selective arterial calcium injection test for localization of gastrinoma. Endocr J. 2020;67:305–51. https://doi.org/10.1507/endocrj.EJ19-0413.

Article  CAS  PubMed  Google Scholar 

Nakano Y, Kitago M, Shinoda M, Nakatsuka S, Kurihara I, Yagi H, et al. Usefulness of selective arterial calcium injection tests for functional pancreatic neuroendocrine tumors. Sci Rep. 2021;11(235):1–7. https://doi.org/10.1038/s41598-020-80538-0.

Article  CAS  Google Scholar 

Faggiano A, Modica R, Calzo F, Camera L, Napolitano V, Altieri B, et al. Lanreotide therapy vs active surveillance in MEN1-related pancreatic neuroendocrine tumors < 2 centimeters. J Clin Endocrinol Metab. 2020;105:78–84. https://doi.org/10.1210/clinem/dgz007.

Article  Google Scholar